MEDIA REZ LLC

Washington, DC · Digital health · Still private

Voice-controlled smart home system integrating router controls, smart lighting, and AI-powered virtual assistant to deliver behavioral sleep medicine therapy

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · mediarez.com

Sector: Digital health
Headquarters: Washington, DC
Total capital: $7.2M

Federal grants: $7.2M; 16 awards · 2015–2026; Sector median 0 awards
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

Latest events

Jun 2026Federal grantHealth and Human S · Phase II · Intervention for Chronic Insufficient Sleep in Young Adult Cancer Patients and Survivors$696K
Sep 2025Federal grantHealth and Human S · Phase I · Patient-directed technology for non-pharmacologic management of cancer pain$404K
Jun 2025Federal grantHealth and Human S · Phase II · Intervention for Chronic Insufficient Sleep in Young Adult Cancer Patients and Survivors$735K
Jul 2023Federal grantHealth and Human S · Phase II · Supplement for an intervention to increase HIV Testing Uptake among Adolescents and Young Adults$100K
Apr 2022Federal grantHealth and Human S · Phase II · An intervention to increase HIV Testing Uptake among Adolescents and Young Adults $382K
Mar 2022Federal grantHealth and Human S · Phase II · Interactive Cognitive Behavioral Therapy for Insomnia$583K
Apr 2021Federal grantHealth and Human S · Phase II · Interactive Cognitive Behavioral Therapy for Insomnia$654K

Show 9 earlier federal awards

Mar 2021Federal grantHealth and Human S · Phase II · An intervention to increase HIV Testing Uptake among Adolescents and Young Adults $518K
Sep 2020Federal grantHealth and Human S · Phase I · Intervention for Chronic Insufficient Sleep in Young Adult Cancer Survivors$400K
Sep 2020Federal grantHealth and Human S · Phase I · Intervention for Chronic Insufficient Sleep in Young Adult Cancer Survivors$400K
Apr 2020Federal grantHealth and Human S · Phase II · Interactive Cognitive Behavioral Therapy for Insomnia$757K
Apr 2020Federal grantHealth and Human S · Phase II · An intervention to increase HIV Testing Uptake among Adolescents and Young Adults $541K
Jul 2018Federal grantHealth and Human S · Phase I · Interactive Cognitive Behavioral Therapy for Insomnia$195K
Aug 2017Federal grantHealth and Human S · Phase I · Infant Slumber Safety: An Immersive Smartphone Experience$225K
Jun 2016Federal grantHealth and Human S · Phase I · Routinizing HIV testing for Adolescents$224K
Aug 2015Federal grantHealth and Human S · Phase I · Interactive Technology for Pediatric HIV/AIDS Treatment Adherence$349K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Digital health

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.